Fundraising FoxVitriVax
Boulder, US · Delaware corporation · 5 known investors
Find your way into VitriVax
Sign up to see every warm intro you have to VitriVax
- Paths you didn't know you had: your email and LinkedIn already hold routes to the VitriVax team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Develops a thermostable, single-injection vaccine formulation platform.
Founders & leadership
TR
Theodore RandolphFounder
RC
Romulo ColindresExecutiveRomulo Colindres is a pharmaceutical executive with experience in medical affairs, epidemiology, clinical development, market access, regulatory affairs, and pharmacovigilance. He leads VitriVax as executive officer and director.
Board
GR
RL
Rene LorenzBoard director
LB
Louise BradyBoard director
Investors · 5
Buff Gold Ventureslisted by Buff Gold VenturesBoulder
How we know: Buff Gold Ventures's portfolio page · Not right? Tell us
Colorado BioScience Associationlisted by Colorado BioScience Association
How we know: Colorado BioScience Association's portfolio page · Not right? Tell us
RA Capitallisted by RA CapitalBoston
How we know: RA Capital's portfolio page · funding news · press coverage · Not right? Tell us
Adjuvant CapitalreportedNew York · $10M – $25M
How we know: a partner's Signal profile · funding news · press coverage · Not right? Tell us
Funding
SEC filings, press & company announcements$29.4M disclosed across 1 of 2 rounds · 2021–2025
- Undisclosed amountSeries AJul 2021Source ↗
▶$29.4MraisedNov 2025 · 83 investors · BiotechnologyRule 506(b)
▶$29.4MraisedNov 2025 · 83 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Glenn RockmanDirector
- Rene LorenzDirector
- Louise BradyDirector
- Theodore RandolphDirector
- Romulo ColindresExecutive Officer, Director, Promoter
- Offering amount
- $37.1M
- Amount sold
- $29.4M
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does VitriVax do?
- Develops a thermostable, single-injection vaccine formulation platform.
- Who founded VitriVax?
- VitriVax was founded by Theodore Randolph.
- Who are VitriVax's investors?
- VitriVax's investors include Buff Gold Ventures, Colorado BioScience Association, CU Healthcare Innovation Fund, RA Capital, Adjuvant Capital.
- How much funding has VitriVax raised?
- VitriVax has disclosed $29.4M raised across 1 of its 2 known rounds.
- Where is VitriVax headquartered?
- VitriVax is headquartered in Boulder, US.